Investments in and Advances to Joint Ventures (Tables)

12 Months Ended

Dec. 31, 2022

Equity Method Investments And Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements as of and for the years ended December 31, 2022, December 31, 2021 and December 31, 2020 (in thousands):

	2022		2021
Current assets	$	289,837	$	246,342
Noncurrent assets		9,961		2,180
Total assets		299,798		248,522
Current liabilities		198,464		175,637
Total liabilities		198,464		175,637
Total joint venture equity	$	101,334	$	72,885

	2022		2021		2020
Revenue	$	483,888	$	402,078	$	450,530
Costs		422,559		351,670		408,319
Net income	$	61,329	$	50,408	$	42,211
Net income attributable to noncontrolling interests	$	29,901	$	24,880	$	20,380

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements as of and for the years ended December 31, 2022 and December 31, 2021 (in thousands):

	2022		2021
Current assets	$	1,610,246	$	1,620,735
Noncurrent assets		491,658		531,261
Total assets		2,101,904		2,151,996
Current liabilities		1,255,297		1,088,985
Noncurrent liabilities		468,056		669,911
Total liabilities		1,723,353		1,758,896
Total joint venture equity	$	378,551	$	393,100
Investments in and advances to unconsolidated joint ventures	$	107,425	$	110,688

	2022		2021		2020
Revenue	$	2,406,407	$	2,709,305	$	1,830,802
Costs		2,325,472		2,536,403		1,709,933
Net income	$	80,935	$	172,902	$	120,869
Equity in earnings of unconsolidated joint ventures	$	16,347	$	36,862	$	30,059